Liwei Wang Selected Research

Aftercare (After-Treatment)

2/2018	Pilot study: safety and effectiveness of simple ultrasound-guided high-intensity focused ultrasound ablating uterine leiomyoma with a diameter greater than 10 cm.
9/2013	Analysis of UGT1A1*28 genotype and SN-38 pharmacokinetics for irinotecan-based chemotherapy in patients with advanced colorectal cancer: results from a multicenter, retrospective study in Shanghai.
8/2012	Meta-analysis of studies in China about changes in P300 latency and amplitude that occur in patients with schizophrenia during treatment with antipsychotic medication.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liwei Wang Research Topics

Disease

103	Neoplasms (Cancer) 03/2024 - 08/2002
36	Stomach Neoplasms (Stomach Cancer) 01/2023 - 08/2002
32	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 01/2003
26	Nasopharyngeal Carcinoma 12/2019 - 10/2002
24	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2003
17	Adenocarcinoma 01/2024 - 03/2004
9	Inflammation (Inflammations) 11/2023 - 01/2012
9	Colorectal Neoplasms (Colorectal Cancer) 08/2020 - 01/2003
8	Breast Neoplasms (Breast Cancer) 03/2024 - 04/2016
8	Carcinogenesis 11/2022 - 12/2010
6	Pain (Aches) 04/2024 - 01/2017
5	Lymphatic Metastasis 01/2019 - 01/2004
4	COVID-19 04/2024 - 10/2022
4	Hypersensitivity (Allergy) 04/2024 - 01/2019
4	Schizophrenia (Dementia Praecox) 04/2024 - 03/2012
4	Postoperative Pain 01/2024 - 01/2017
4	Cognitive Dysfunction 10/2023 - 01/2017
4	Wounds and Injuries (Trauma) 01/2023 - 05/2016
4	Hepatocellular Carcinoma (Hepatoma) 09/2018 - 05/2013
3	Infections 04/2024 - 01/2021
3	Neuroinflammatory Diseases 12/2023 - 01/2017
3	Hypoxia (Hypoxemia) 09/2023 - 03/2016
3	Diarrhea 06/2023 - 09/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 10/2017
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 03/2020
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 04/2014
3	Lung Neoplasms (Lung Cancer) 12/2019 - 12/2013
3	Carcinoma (Carcinomatosis) 11/2013 - 06/2010
2	Pneumonia (Pneumonitis) 04/2024 - 01/2021
2	Chronic Pain 12/2023 - 01/2022
2	Anorexia 01/2023 - 10/2017
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2023 - 01/2022
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 05/2020

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 01/2024 - 07/2003
24	Chloride Channels (Chloride Channel)IBA 03/2021 - 01/2007
20	Biomarkers (Surrogate Marker)IBA 01/2024 - 08/2012
15	ChloridesIBA 03/2021 - 10/2002
13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012 - 01/2003
8	Sp1 Transcription FactorIBA 07/2008 - 12/2003
7	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2004
7	Long Noncoding RNAIBA 01/2023 - 12/2014
7	Messenger RNA (mRNA)IBA 03/2021 - 01/2004
5	Antipsychotic Agents (Antipsychotics)IBA 04/2024 - 03/2012
5	CytokinesIBA 01/2024 - 08/2005
5	Gemcitabine FDA Link 01/2024 - 08/2011
5	Protein Isoforms (Isoforms)IBA 10/2022 - 12/2010
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2021 - 02/2016
5	Caspase 3 (Caspase-3)IBA 03/2021 - 06/2005
5	mithramycin AIBA 08/2011 - 05/2007
4	Trastuzumab (Herceptin)FDA Link 03/2024 - 02/2016
4	Tyrosine Kinase InhibitorsIBA 01/2024 - 05/2016
4	SolutionsIBA 11/2023 - 10/2002
4	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 10/2018
4	Sevoflurane (Ultane)FDA LinkGeneric 01/2022 - 12/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2013
4	AntigensIBA 11/2021 - 07/2013
4	Irinotecan (Camptosar)FDA LinkGeneric 08/2021 - 09/2013
4	apatinibIBA 01/2018 - 09/2013
4	Cyclin D1IBA 01/2016 - 06/2005
4	Cisplatin (Platino)FDA LinkGeneric 02/2015 - 10/2009
4	Bevacizumab (Avastin)FDA Link 01/2015 - 04/2007
3	LipidsIBA 03/2024 - 06/2014
3	MicroRNAs (MicroRNA)IBA 01/2023 - 11/2013
3	LigandsIBA 01/2022 - 01/2017
3	Leucovorin (Folinic Acid)FDA Link 08/2021 - 10/2018
3	folfirinoxIBA 08/2021 - 05/2021
3	PlatinumIBA 07/2021 - 01/2017
3	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2015
3	VimentinIBA 01/2021 - 01/2020
3	Lactic Acid (Lactate)FDA LinkGeneric 11/2020 - 01/2015
3	Tumor Biomarkers (Tumor Markers)IBA 02/2019 - 02/2012
3	Small Interfering RNA (siRNA)IBA 09/2018 - 12/2007
3	Celecoxib (Celebrex)FDA Link 01/2018 - 03/2004
3	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2015 - 02/2012
3	ErbB Receptors (EGF Receptor)IBA 01/2013 - 05/2007
2	CalciumIBA 04/2024 - 01/2020
2	Clozapine (Clozaril)FDA LinkGeneric 04/2024 - 01/2023
2	Histones (Histone)IBA 03/2024 - 10/2014
2	Interleukin-8 (Interleukin 8)IBA 03/2024 - 01/2004
2	human ERBB2 proteinIBA 03/2024 - 02/2016
2	pertuzumabIBA 03/2024 - 01/2019
2	AnthracyclinesIBA 03/2024 - 01/2020
2	Olanzapine (Zyprexa)FDA Link 02/2024 - 01/2019
2	FlavonoidsIBA 01/2024 - 11/2023
2	Opioid Analgesics (Opioids)IBA 01/2024 - 01/2022
2	AlkaloidsIBA 01/2024 - 04/2023
2	Protein Kinases (Protein Kinase)IBA 10/2023 - 03/2016
2	C-Reactive ProteinIBA 06/2023 - 01/2017
2	AluminumIBA 02/2023 - 01/2015
2	Dexmedetomidine FDA Link 01/2023 - 01/2019
2	Therapeutic UsesIBA 01/2023 - 01/2021
2	InflammasomesIBA 01/2023 - 01/2021
2	Monoclonal AntibodiesIBA 01/2023 - 04/2007

Therapy/Procedure

27	Therapeutics 03/2024 - 11/2006
20	Drug Therapy (Chemotherapy) 01/2024 - 10/2009
5	Immunotherapy 01/2023 - 04/2021
4	Radiotherapy 11/2020 - 01/2013
3	Precision Medicine 02/2019 - 04/2015
3	Aftercare (After-Treatment) 02/2018 - 08/2012